Of note, the effects of several agents from the group of angiotensin receptor blockers or angiotensin-converting enzyme inhibitors on AF recurrence have been tested in experimental and clinical settings with variable results [80,81,82], indicating that the blockade of RAAS syndrome is not efficient in AF episode prevention. Here, ACE is linked to atrial fibrillation.